These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29326845)

  • 61. Utilization and Expenditures of Vertebral Augmentation Continue to Decline: An Analysis in Fee-For-Service (FFS) Recipients from 2009 to 2018.
    Manchikanti L; Senapathi SHV; Milburn JM; Brook AL; Vangala BP; Pampati V; Sanapati MR; Hirsch JA
    Pain Physician; 2021 Sep; 24(6):401-415. PubMed ID: 34554681
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Trends in laboratory test volumes for Medicare Part B reimbursements, 2000-2010.
    Shahangian S; Alspach TD; Astles JR; Yesupriya A; Dettwyler WK
    Arch Pathol Lab Med; 2014 Feb; 138(2):189-203. PubMed ID: 23738761
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Trends of Expenditures and Utilization of Facet Joint Interventions in Fee-For-Service (FFS) Medicare Population from 2009-2018.
    Manchikanti L; Pampati V; Soin A; Vanaparthy R; Sanapati MR; Kaye AD; Hirsch JA
    Pain Physician; 2020 May; 23(3S):S129-S147. PubMed ID: 32503360
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mental Health Services Utilization and Expenditures Among Children Enrolled in Employer-Sponsored Health Plans.
    Walter AW; Yuan Y; Cabral HJ
    Pediatrics; 2017 May; 139(Suppl 2):S127-S135. PubMed ID: 28562310
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Insurance expenditures on bipolar disorder: clinical and parity implications.
    Peele PB; Xu Y; Kupfer DJ
    Am J Psychiatry; 2003 Jul; 160(7):1286-90. PubMed ID: 12832243
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Trends in Total and Out-of-Pocket Expenditures for Visits to Primary Care Physicians, by Insurance Type, 2002-2017.
    Johansen ME; Yun JDY
    Ann Fam Med; 2020 Sep; 18(5):430-437. PubMed ID: 32928759
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Comparison of Tuberculin Skin Test (TST) and T-SPOT.TB Tests for Diagnosis of Latent Tuberculosis Infection (LTBI) in HIV-infected Patients].
    Binay UD; Fincancı M; Fersan E; Karakeçili F
    Mikrobiyol Bul; 2019 Oct; 53(4):388-400. PubMed ID: 31709936
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Association of Implementing an Incentive Metric in the Oregon Medicaid Program With Effective Contraceptive Use.
    Rodriguez MI; Meath T; Huang J; Darney BG; McConnell KJ
    JAMA Netw Open; 2020 Aug; 3(8):e2012540. PubMed ID: 32756928
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting.
    Nicol MP; Davies MA; Wood K; Hatherill M; Workman L; Hawkridge A; Eley B; Wilkinson KA; Wilkinson RJ; Hanekom WA; Beatty D; Hussey G
    Pediatrics; 2009 Jan; 123(1):38-43. PubMed ID: 19117858
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Can Primary Care Drive Tuberculosis Elimination? Increasing Latent Tuberculosis Infection Testing and Treatment Initiation at a Community Health Center with a Large Non-U.S.-born Population.
    Tang AS; Mochizuki T; Dong Z; Flood J; Katrak SS
    J Immigr Minor Health; 2023 Aug; 25(4):803-815. PubMed ID: 36652151
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Skin tests for the detection of Mycobacterial infections: achievements, current perspectives, and implications for other diseases.
    Duthie MS; Reed SG
    Appl Microbiol Biotechnol; 2021 Jan; 105(2):503-508. PubMed ID: 33394146
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The single recombinant M. tuberculosis protein DPPD provides enhanced performance of skin testing among HIV-infected tuberculosis patients.
    Badaro R; Machado BAS; Duthie MS; Araujo-Neto CA; Pedral-Sampaio D; Nakatani M; Reed SG
    AMB Express; 2020 Jul; 10(1):133. PubMed ID: 32737693
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Estimates of Testing for Latent Tuberculosis Infection and Cost, United States, 2013.
    Marks SM; Woodruff RY; Owusu-Edusei K; Asay GRB; Hill AN
    Public Health Rep; 2019; 134(5):522-527. PubMed ID: 31339816
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prevalence, expenditures, utilization, and payment for persons with MS in insured populations.
    Pope GC; Urato CJ; Kulas ED; Kronick R; Gilmer T
    Neurology; 2002 Jan; 58(1):37-43. PubMed ID: 11781403
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Utilization and cost of diagnostic methods for sexually transmitted infection screening among insured American youth, 2008.
    Owusu-Edusei K; Nguyen HT; Gift TL
    Sex Transm Dis; 2013 May; 40(5):354-61. PubMed ID: 23588123
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tuberculosis Test Usage and Medical Expenditures from Outpatient Insurance Claims Data, 2013.
    Owusu-Edusei K; Winston CA; Marks SM; Langer AJ; Miramontes R
    Tuberc Res Treat; 2017; 2017():3816432. PubMed ID: 29326845
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tuberculosis hospitalization expenditures per patient from private health insurance claims data, 2010-2014.
    Owusu-Edusei K; Marks SM; Miramontes R; Stockbridge EL; Winston CA
    Int J Tuberc Lung Dis; 2017 Apr; 21(4):398-404. PubMed ID: 28284254
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.